Favipiravir is the new drug that is being hailed as a treatment for Covid-19. Limited, incomplete studies in China, Japan, and Russia have shown benefit, but authors of the study urge caution. ThePrint’s Sandhya Ramesh explains why this drug is gaining attention and what its long list of side effects are.